Talkmed Group Stock

Talkmed Group ROCE 2024

Talkmed Group ROCE

0.43

Ticker

5G3.SI

ISIN

SG2G61000003

In 2024, Talkmed Group's return on capital employed (ROCE) was 0.43, a -1.99% increase from the 0.44 ROCE in the previous year.

Talkmed Group Aktienanalyse

What does Talkmed Group do?

Talkmed Group Ltd. is a leading healthcare company in Asia specializing in the development, manufacturing, and marketing of innovative diagnostic and therapeutic solutions in oncology. The company was founded in 2002 by Dr. Ang Peng Tiam, with a focus on providing high-quality cancer treatments. Since its inception, Talkmed Group Ltd. has become a pioneer in cancer research and treatment in Asia and has grown to become one of the largest providers of cancer treatments in the region. The company's business model is centered around offering high-quality diagnostic solutions and innovative cancer therapies to provide better patient care. They work closely with pharmaceutical companies to develop and market innovative medications and therapies that contribute to higher survival rates and improved quality of life for cancer patients. In addition, Talkmed Group Ltd. is involved in the development of medical diagnostic and monitoring devices tailored to the needs of cancer patients. They offer a range of treatments and programs that aim to provide accessible, affordable, and high-quality care for cancer patients. Overall, Talkmed Group Ltd. is an innovative company dedicated to improving the lives of cancer patients through the development, manufacturing, and marketing of diagnostic and therapeutic solutions in oncology. Talkmed Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Talkmed Group's Return on Capital Employed (ROCE)

Talkmed Group's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Talkmed Group's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Talkmed Group's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Talkmed Group’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Talkmed Group stock

What is the ROCE (Return on Capital Employed) of Talkmed Group this year?

The ROCE of Talkmed Group is 0.43 undefined this year.

How has the ROCE (Return on Capital Employed) of Talkmed Group developed compared to the previous year?

The ROCE of Talkmed Group has increased by -1.99% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Talkmed Group?

A high Return on Capital Employed (ROCE) indicates that Talkmed Group has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Talkmed Group?

A low ROCE (Return on Capital Employed) can indicate that Talkmed Group has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Talkmed Group impact the company?

An increase in the ROCE of Talkmed Group can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Talkmed Group affect the company?

A decrease in ROCE of Talkmed Group can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Talkmed Group?

Some factors that can affect Talkmed Group's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Talkmed Group so important for investors?

The ROCE of Talkmed Group is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Talkmed Group take to improve the ROCE?

To improve the ROCE, Talkmed Group can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Talkmed Group pay?

Over the past 12 months, Talkmed Group paid a dividend of 0.02 SGD . This corresponds to a dividend yield of about 5.52 %. For the coming 12 months, Talkmed Group is expected to pay a dividend of 0.02 SGD.

What is the dividend yield of Talkmed Group?

The current dividend yield of Talkmed Group is 5.52 %.

When does Talkmed Group pay dividends?

Talkmed Group pays a quarterly dividend. This is distributed in the months of May, September, May, September.

How secure is the dividend of Talkmed Group?

Talkmed Group paid dividends every year for the past 11 years.

What is the dividend of Talkmed Group?

For the upcoming 12 months, dividends amounting to 0.02 SGD are expected. This corresponds to a dividend yield of 5.52 %.

In which sector is Talkmed Group located?

Talkmed Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Talkmed Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Talkmed Group from 8/22/2024 amounting to 0.014 SGD, you needed to have the stock in your portfolio before the ex-date on 8/14/2024.

When did Talkmed Group pay the last dividend?

The last dividend was paid out on 8/22/2024.

What was the dividend of Talkmed Group in the year 2023?

In the year 2023, Talkmed Group distributed 0.024 SGD as dividends.

In which currency does Talkmed Group pay out the dividend?

The dividends of Talkmed Group are distributed in SGD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Talkmed Group

Our stock analysis for Talkmed Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Talkmed Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.